Cost-effectiveness study on the provox®2 and the Groningen ultra low resistance tracheoesophageal shunt prostheses

Completed

• Conditions: Tracheoesophageal shunt prostheses; Ear, Nose and Throat; Throat prostheses

• Registration Number: ISRCTN31438086
• Lead Sponsor: niversity Medical Center Groningen (UMCG) (The Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2006-12-28
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 80

Inclusion Criteria

Patients from our outpatient clinic (Ear, Nose and Throat [ENT] Department at University Medical Centre Groningen [UMCG]): post-laryngectomees that use a TracheoEsophageal (TE) shunt prosthesis for their phonation.

Exclusion Criteria

1. Patients younger than 45 or older than 70
2. Patients that have a metastasis or recurrence of their previous larynx carcinoma
3. Patients that smoke tobacco

Study & Design

• Study Type: Interventional
• Study Design: Not specified